Babcock & Wilcox Enterprises Inc
SWB:UBW1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Babcock & Wilcox Enterprises Inc
SWB:UBW1
|
US |
|
S
|
Syra Health Corp
NASDAQ:SYRA
|
US |
|
J
|
JSR Corp
F:JYR
|
JP |
|
Babcock & Wilcox Enterprises Inc
NYSE:BW
|
US |
|
Fleury Michon SA
F:4XZ
|
FR |
|
H
|
Heidelberger Druckmaschinen AG
XMUN:HDD
|
DE |
|
G
|
Garmin Ltd
DUS:GEY
|
CH |
|
M
|
Medtronic PLC
DUS:2M6
|
IE |
|
O
|
OWC Pharmaceutical Research Corp
OTC:OWCP
|
IL |
|
Z
|
Z Holdings Corp
OTC:YAHOF
|
JP |
|
U
|
UBE Corp
DUS:UBE
|
JP |
|
C
|
Constellation Brands Inc
F:CB1A
|
US |
|
Okinawa Cellular Telephone Co
OTC:OKCTF
|
JP |
|
A
|
Amphastar Pharmaceuticals Inc
SWB:29A
|
US |
|
Associated British Foods PLC
F:AFO2
|
UK |
|
W
|
Weibo Corp
XMUN:2WBA
|
CN |
|
V
|
Vita 34 AG
F:V3V
|
DE |
|
M
|
MI Technovation Bhd
KLSE:MI
|
MY |
|
K
|
Kirby Corp
F:KIY
|
US |
|
G
|
General Motors Co
XMUN:8GM
|
US |
|
MarineMax Inc
NYSE:HZO
|
US |
|
A
|
AECOM
F:E6Z
|
US |
|
H
|
Heidelberger Druckmaschinen AG
XBER:HDD
|
DE |
|
Recce Pharmaceuticals Ltd
OTC:RECEF
|
AU |
Wall St Price Targets
UBW1 Price Targets Summary
Babcock & Wilcox Enterprises Inc
According to Wall Street analysts, the average 1-year price target for UBW1 is 17.17 EUR with a low forecast of 14.21 EUR and a high forecast of 21.73 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UBW1's stock price target?
Price Target
17.17
EUR
According to Wall Street analysts, the average 1-year price target for UBW1 is 17.17 EUR with a low forecast of 14.21 EUR and a high forecast of 21.73 EUR.
What is the Revenue forecast for Babcock & Wilcox Enterprises Inc?
Projected CAGR
42%
Over the last 12 years, the compound annual growth rate for Revenue has been -9%. The projected CAGR for the next 3 years is 42%.
What is the Operating Income forecast for Babcock & Wilcox Enterprises Inc?
Projected CAGR
87%
Over the last 12 years, the compound annual growth rate for Operating Income has been -17%. The projected CAGR for the next 3 years is 87%.
